156 related articles for article (PubMed ID: 8165385)
1. A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene.
Kaplan PW; Allen RP; Buchholz DW; Walters JK
Sleep; 1993 Dec; 16(8):717-23. PubMed ID: 8165385
[TBL] [Abstract][Full Text] [Related]
2. Entacapone prolongs the reduction of PLM by levodopa/carbidopa in restless legs syndrome.
Polo O; Ylä-Sahra R; Hirvonen K; Karvinen J; Vahteristo M; Ellmén J
Clin Neuropharmacol; 2007; 30(6):335-44. PubMed ID: 18090458
[TBL] [Abstract][Full Text] [Related]
3. L-DOPA/carbidopa for nocturnal movement disorders in uremia.
Walker SL; Fine A; Kryger MH
Sleep; 1996 Apr; 19(3):214-8. PubMed ID: 8723378
[TBL] [Abstract][Full Text] [Related]
4. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
[TBL] [Abstract][Full Text] [Related]
5. The treatment of the restless leg syndrome with or without periodic leg movements in sleep.
Montplaisir J; Lapierre O; Warnes H; Pelletier G
Sleep; 1992 Oct; 15(5):391-5. PubMed ID: 1360697
[TBL] [Abstract][Full Text] [Related]
6. Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients.
Earley CJ; Allen RP
Sleep; 1996 Dec; 19(10):801-10. PubMed ID: 9085489
[TBL] [Abstract][Full Text] [Related]
7. A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms.
Collado-Seidel V; Kazenwadel J; Wetter TC; Kohnen R; Winkelmann J; Selzer R; Oertel WH; Trenkwalder C
Neurology; 1999 Jan; 52(2):285-90. PubMed ID: 9932945
[TBL] [Abstract][Full Text] [Related]
8. Double-blind evaluation of clonazepam on periodic leg movements in sleep.
Peled R; Lavie P
J Neurol Neurosurg Psychiatry; 1987 Dec; 50(12):1679-81. PubMed ID: 3437302
[TBL] [Abstract][Full Text] [Related]
9. Restless legs syndrome and periodic movements in sleep: physiopathology and treatment with L-dopa.
Montplaisir J; Godbout R; Poirier G; Bédard MA
Clin Neuropharmacol; 1986; 9(5):456-63. PubMed ID: 3021323
[TBL] [Abstract][Full Text] [Related]
10. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.
Garcia-Borreguero D; Larrosa O; Williams AM; Albares J; Pascual M; Palacios JC; Fernandez C
Neurology; 2010 Jun; 74(23):1897-904. PubMed ID: 20427750
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic agents in restless legs syndrome and periodic limb movements of sleep: response and complications of extended treatment in 49 cases.
Becker PM; Jamieson AO; Brown WD
Sleep; 1993 Dec; 16(8):713-6. PubMed ID: 7909374
[TBL] [Abstract][Full Text] [Related]
12. Gabapentin versus levodopa-c for the treatment of restless legs syndrome in hemodialysis patients: a randomized clinical trial.
Razazian N; Azimi H; Heidarnejadian J; Afshari D; Ghadami MR
Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):271-8. PubMed ID: 25758874
[TBL] [Abstract][Full Text] [Related]
13. Rapid onset of action of levodopa in restless legs syndrome: a double-blind, randomized, multicenter, crossover trial.
Benes H; Kurella B; Kummer J; Kazenwadel J; Selzer R; Kohnen R
Sleep; 1999 Dec; 22(8):1073-81. PubMed ID: 10617168
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic treatment of restless legs and rebound phenomenon.
Guilleminault C; Cetel M; Philip P
Neurology; 1993 Feb; 43(2):445. PubMed ID: 8094897
[No Abstract] [Full Text] [Related]
15. Children show individual night-to-night variability of periodic limb movements in sleep.
Picchietti MA; Picchietti DL; England SJ; Walters AS; Couvadelli BV; Lewin DS; Hening W
Sleep; 2009 Apr; 32(4):530-5. PubMed ID: 19413147
[TBL] [Abstract][Full Text] [Related]
16. Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study.
Brodeur C; Montplaisir J; Godbout R; Marinier R
Neurology; 1988 Dec; 38(12):1845-8. PubMed ID: 3057399
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of the restless legs syndrome with carbidopa/levodopa.
Allen RP; Earley CJ
Sleep; 1996 Apr; 19(3):205-13. PubMed ID: 8723377
[TBL] [Abstract][Full Text] [Related]
18. Treatment of periodic leg movements with a dopaminergic agonist in subjects with total spinal cord lesions.
de Mello MT; Poyares DL; Tufik S
Spinal Cord; 1999 Sep; 37(9):634-7. PubMed ID: 10490854
[TBL] [Abstract][Full Text] [Related]
19. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial.
Trenkwalder C; Stiasny K; Pollmächer T; Wetter T; Schwarz J; Kohnen R; Kazenwadel J; Krüger HP; Ramm S; Künzel M
Sleep; 1995 Oct; 18(8):681-8. PubMed ID: 8560135
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of idiopathic and uremic restless legs syndrome with L-dopa--a double-blind cross-over study].
Wetter TC; Trenkwalder C; Stiasny K; Pollmächer T; Kazenwadel J; Kohnen R; Künzel M; Oertel WH
Wien Med Wochenschr; 1995; 145(17-18):525-7. PubMed ID: 8588396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
